HUS2100047I1 - Egy androgén receptor modulátor kristályos formái - Google Patents

Egy androgén receptor modulátor kristályos formái

Info

Publication number: HUS2100047I1
Authority: HU; Hungary
Prior art keywords: androgen receptor; crystalline forms; receptor modulator; modulator; androgen
Prior art date: 2012-06-07

Application number

HUS2100047C

Other languages

English (en)

Original Assignee

Aragon Pharmaceuticals Inc

Sloan Kettering Inst Cancer Res

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-06-07

Filing date

2021-11-04

Publication date

2021-11-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49712550&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUS2100047(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2021-11-04 Application filed by Aragon Pharmaceuticals Inc, Sloan Kettering Inst Cancer Res filed Critical Aragon Pharmaceuticals Inc

2021-11-29 Publication of HUS2100047I1 publication Critical patent/HUS2100047I1/hu

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Tropical Medicine & Parasitology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

HUS2100047C 2012-06-07 2021-11-04 Egy androgén receptor modulátor kristályos formái HUS2100047I1 (hu)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201261656888P	2012-06-07	2012-06-07
EP19169275.5A EP3533792B1 (en)	2012-06-07	2013-06-04	Crystalline forms of an androgen receptor modulator

Publications (1)

Publication Number	Publication Date
HUS2100047I1 true HUS2100047I1 (hu)	2021-11-29

Family

ID=49712550

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
HUE19169275A HUE054595T2 (hu)	2012-06-07	2013-06-04	Egy androgén receptor modulátor kristályos formái
HUE13800681A HUE038082T2 (hu)	2012-06-07	2013-06-04	Androgén receptor modulátor kristályformái
HUE18157435A HUE050357T2 (hu)	2012-06-07	2013-06-04	Androgén receptor modulátor kristályos formái
HUS2100047C HUS2100047I1 (hu)	2012-06-07	2021-11-04	Egy androgén receptor modulátor kristályos formái

Family Applications Before (3)

Application Number	Title	Priority Date	Filing Date
HUE19169275A HUE054595T2 (hu)	2012-06-07	2013-06-04	Egy androgén receptor modulátor kristályos formái
HUE13800681A HUE038082T2 (hu)	2012-06-07	2013-06-04	Androgén receptor modulátor kristályformái
HUE18157435A HUE050357T2 (hu)	2012-06-07	2013-06-04	Androgén receptor modulátor kristályos formái

Country Status (45)

Country	Link
US (9)	US9481663B2 (hu)
EP (4)	EP3922629A1 (hu)
JP (3)	JP6182209B2 (hu)
KR (2)	KR102195916B1 (hu)
CN (3)	CN105693692A (hu)
AU (3)	AU2013271751B2 (hu)
BR (1)	BR112014030678A2 (hu)
CA (4)	CA3114726A1 (hu)
CL (1)	CL2014003331A1 (hu)
CO (1)	CO7240407A2 (hu)
CR (2)	CR20190331A (hu)
CY (4)	CY1120393T1 (hu)
DK (3)	DK3348553T3 (hu)
EA (3)	EA033956B1 (hu)
EC (1)	ECSP14030098A (hu)
ES (3)	ES2809738T3 (hu)
FR (1)	FR21C1050I2 (hu)
GT (1)	GT201400283A (hu)
HK (2)	HK1210175A1 (hu)
HR (3)	HRP20180902T1 (hu)
HU (4)	HUE054595T2 (hu)
IL (4)	IL236055A0 (hu)
IN (1)	IN2014DN10084A (hu)
LT (4)	LT3533792T (hu)
LU (1)	LUC00236I2 (hu)
ME (2)	ME03081B (hu)
MX (1)	MX356754B (hu)
MY (1)	MY187500A (hu)
NI (1)	NI201400142A (hu)
NL (1)	NL301144I2 (hu)
NO (1)	NO2021046I1 (hu)
NZ (2)	NZ702203A (hu)
PE (2)	PE20200725A1 (hu)
PH (2)	PH12014502714B1 (hu)
PL (3)	PL3533792T3 (hu)
PT (3)	PT2858985T (hu)
RS (3)	RS61988B1 (hu)
SG (3)	SG10201610249TA (hu)
SI (3)	SI3533792T1 (hu)
SM (3)	SMT202000496T1 (hu)
TR (1)	TR201808939T4 (hu)
TW (1)	TWI532732B (hu)
UA (2)	UA115665C2 (hu)
WO (1)	WO2013184681A1 (hu)
ZA (1)	ZA201500076B (hu)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2008119015A2 (en)	2007-03-27	2008-10-02	Sloan-Kettering Institute For Cancer Research	Synthesis of thiohydantoins
EP4282449A3 (en)	2009-01-12	2024-02-28	University Of Massachusetts Lowell	Polyisobutylene-based polyurethanes
CN104169266A (zh)	2011-12-16	2014-11-26	奥乐玛药物股份有限公司	新的苯并吡喃化合物、其组合物和用途
LT3533792T (lt)	2012-06-07	2021-07-26	Aragon Pharmaceuticals, Inc.	Androgeno receptoriaus moduliatoriaus kristalinės formos
CN109897004A (zh)	2012-09-11	2019-06-18	麦迪威森前列腺医疗有限责任公司	恩杂鲁胺制剂
PE20150765A1 (es)	2012-09-26	2015-05-15	Aragon Pharmaceuticals Inc	Antiandrogenos para el tratamiento del cancer de prostata resistente a la castracion no metastasico
CN104520345B (zh)	2012-11-21	2017-10-03	马萨诸塞州大学	高强度聚氨异丁烯聚氨甲酸酯
JOP20200097A1 (ar) *	2013-01-15	2017-06-16	Aragon Pharmaceuticals Inc	معدل مستقبل أندروجين واستخداماته
CN106795152B (zh) *	2014-08-26	2020-01-31	安斯达尔生物技术有限责任公司	蛋白激酶抑制剂
CA2969675C (en)	2014-12-05	2023-06-06	Aragon Pharmaceuticals, Inc.	Anticancer compositions
SMT202400518T1 (it) *	2014-12-05	2025-01-14	Aragon Pharmaceuticals Inc	Composizioni anticancro
PL3226842T3 (pl)	2014-12-05	2021-07-12	Aragon Pharmaceuticals, Inc.	Kompozycje przeciwnowotworowe
EP4351278A3 (en)	2014-12-19	2024-06-12	Lutron Technology Company LLC	Multi-channel lighting fixture having multiple light-emitting diode drivers
MX2018014846A (es)	2016-06-03	2019-03-14	Aragon Pharmaceuticals Inc	Composiciones antineoplasicas.
EP3555061B1 (en)	2016-12-13	2023-06-07	Watson Laboratories Inc.	Solid state forms of apalutamide
WO2018165273A1 (en)	2017-03-07	2018-09-13	Cardiac Pacemakers, Inc.	Hydroboration/oxidation of allyl-terminated polyisobutylene
CN110997746B (zh)	2017-08-17	2021-12-28	心脏起搏器股份公司	用于增强的耐久性的光交联聚合物
KR20200070334A (ko)	2017-10-16	2020-06-17	아라곤 파마슈티컬스, 인코포레이티드	비-전이성 거세-저항성 전립선암의 치료를 위한 항-안드로겐
WO2019135254A1 (en)	2018-01-02	2019-07-11	Mylan Laboratories Limited	Apalutamide polymorphs and their preparation thereof
WO2019143629A1 (en)	2018-01-17	2019-07-25	Cardiac Pacemakers, Inc.	End-capped polyisobutylene polyurethane
CA3104026A1 (en) *	2018-06-20	2019-12-26	Crystal Pharmaceutical (Suzhou) Co., Ltd.	Crystal form of arn-509, preparation method therefor and use thereof
WO2020049598A2 (en)	2018-09-08	2020-03-12	Cipla Limited	Apalutamide polymorphs
IT201900003839A1 (it)	2019-03-15	2020-09-15	Olon Spa	Sintesi di apalutamide amorfa stabile
WO2020234817A1 (en) *	2019-05-21	2020-11-26	Laurus Labs Limited	Polymorphic forms of apalutamide and its preparation thereof
IT201900010593A1 (it)	2019-07-01	2021-01-01	Dipharma Francis Srl	Forma cristallina di un inibitore di recettori degli androgeni
US20220281836A1 (en) *	2019-08-22	2022-09-08	Dr. Reddy's Laboratories Limited	Process for the preparation of apalutamide
IT201900015974A1 (it)	2019-09-10	2021-03-10	Olon Spa	Apalutamide cristallina stabile in forma pura e processo per la sua preparazione
CN110590740A (zh) *	2019-09-20	2019-12-20	武汉大学	一种阿帕鲁胺化合物及其药物制剂
WO2022049265A1 (en)	2020-09-04	2022-03-10	Synthon B.V.	Improved process for preparation of apalutamide
WO2023143090A1 (zh) *	2022-01-25	2023-08-03	成都苑东生物制药股份有限公司	一种阿帕他胺溶剂化物新晶型及其制备方法
CN115536634B (zh) *	2022-10-17	2024-06-11	上海博悦生物科技有限公司	一种阿帕他胺的合成方法
CN116332907A (zh) *	2023-03-16	2023-06-27	奥锐特药业股份有限公司	一种无定形阿帕他胺的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5323907A (en)	1992-06-23	1994-06-28	Multi-Comp, Inc.	Child resistant package assembly for dispensing pharmaceutical medications
US7709517B2 (en)	2005-05-13	2010-05-04	The Regents Of The University Of California	Diarylhydantoin compounds
CN101032483B (zh)	2006-03-09	2011-05-04	陈德桂	调节雄激素受体活性的乙内酰脲衍生物及其应用
PL2368550T3 (pl) *	2006-03-27	2014-01-31	Univ California	Modulator receptorów androgenowych do leczenia raka gruczołu krokowego i chorób związanych z receptorami androgenów
KR101519705B1 (ko) *	2006-03-29	2015-05-12	더 리전트 오브 더 유니버시티 오브 캘리포니아	디아릴티오히단토인 화합물
WO2008119015A2 (en)	2007-03-27	2008-10-02	Sloan-Kettering Institute For Cancer Research	Synthesis of thiohydantoins
EP3357917A1 (en) *	2010-02-16	2018-08-08	Aragon Pharmaceuticals, Inc.	Androgen receptor modulators and uses thereof
LT3533792T (lt)	2012-06-07	2021-07-26	Aragon Pharmaceuticals, Inc.	Androgeno receptoriaus moduliatoriaus kristalinės formos
CA3104026A1 (en)	2018-06-20	2019-12-26	Crystal Pharmaceutical (Suzhou) Co., Ltd.	Crystal form of arn-509, preparation method therefor and use thereof

2013
- 2013-06-04 LT LTEP19169275.5T patent/LT3533792T/lt unknown
- 2013-06-04 RS RS20210739A patent/RS61988B1/sr unknown
- 2013-06-04 EP EP21171579.2A patent/EP3922629A1/en active Pending
- 2013-06-04 RS RS20200913A patent/RS60617B1/sr unknown
- 2013-06-04 SG SG10201610249TA patent/SG10201610249TA/en unknown
- 2013-06-04 CR CR20190331A patent/CR20190331A/es unknown
- 2013-06-04 CA CA3114726A patent/CA3114726A1/en active Pending
- 2013-06-04 EA EA201791592A patent/EA033956B1/ru unknown
- 2013-06-04 WO PCT/US2013/044116 patent/WO2013184681A1/en active Application Filing
- 2013-06-04 KR KR1020197033592A patent/KR102195916B1/ko active Active
- 2013-06-04 HU HUE19169275A patent/HUE054595T2/hu unknown
- 2013-06-04 ES ES18157435T patent/ES2809738T3/es active Active
- 2013-06-04 SM SM20200496T patent/SMT202000496T1/it unknown
- 2013-06-04 SG SG10201610248SA patent/SG10201610248SA/en unknown
- 2013-06-04 PL PL19169275T patent/PL3533792T3/pl unknown
- 2013-06-04 PE PE2019002096A patent/PE20200725A1/es unknown
- 2013-06-04 PL PL13800681T patent/PL2858985T3/pl unknown
- 2013-06-04 EP EP13800681.2A patent/EP2858985B1/en active Active
- 2013-06-04 ES ES13800681.2T patent/ES2670683T3/es active Active
- 2013-06-04 AU AU2013271751A patent/AU2013271751B2/en active Active
- 2013-06-04 EA EA201992010A patent/EA201992010A1/ru unknown
- 2013-06-04 PE PE2014002383A patent/PE20150631A1/es active IP Right Grant
- 2013-06-04 SI SI201331894T patent/SI3533792T1/sl unknown
- 2013-06-04 SM SM20180311T patent/SMT201800311T1/it unknown
- 2013-06-04 DK DK18157435.1T patent/DK3348553T3/da active
- 2013-06-04 CN CN201610202980.2A patent/CN105693692A/zh active Pending
- 2013-06-04 MX MX2014015005A patent/MX356754B/es active IP Right Grant
- 2013-06-04 EP EP18157435.1A patent/EP3348553B1/en not_active Revoked
- 2013-06-04 LT LTEP13800681.2T patent/LT2858985T/lt unknown
- 2013-06-04 CN CN201380041652.3A patent/CN104619692A/zh active Pending
- 2013-06-04 DK DK19169275.5T patent/DK3533792T3/da active
- 2013-06-04 IN IN10084DEN2014 patent/IN2014DN10084A/en unknown
- 2013-06-04 EA EA201492272A patent/EA028791B1/ru unknown
- 2013-06-04 ME MEP-2018-158A patent/ME03081B/me unknown
- 2013-06-04 ES ES19169275T patent/ES2875932T3/es active Active
- 2013-06-04 DK DK13800681.2T patent/DK2858985T3/en active
- 2013-06-04 CA CA2875767A patent/CA2875767C/en active Active
- 2013-06-04 ME MEP-2020-163A patent/ME03815B/me unknown
- 2013-06-04 TR TR2018/08939T patent/TR201808939T4/tr unknown
- 2013-06-04 SI SI201331010T patent/SI2858985T1/sl unknown
- 2013-06-04 CA CA3008345A patent/CA3008345C/en active Active
- 2013-06-04 BR BR112014030678A patent/BR112014030678A2/pt not_active Application Discontinuation
- 2013-06-04 HU HUE13800681A patent/HUE038082T2/hu unknown
- 2013-06-04 US US14/406,520 patent/US9481663B2/en active Active
- 2013-06-04 CN CN202110417935.XA patent/CN113135892A/zh active Pending
- 2013-06-04 EP EP19169275.5A patent/EP3533792B1/en active Active
- 2013-06-04 PL PL18157435T patent/PL3348553T3/pl unknown
- 2013-06-04 NZ NZ702203A patent/NZ702203A/en unknown
- 2013-06-04 LT LTEP18157435.1T patent/LT3348553T/lt unknown
- 2013-06-04 SM SM20210355T patent/SMT202100355T1/it unknown
- 2013-06-04 RS RS20180680A patent/RS57370B1/sr unknown
- 2013-06-04 CA CA3055660A patent/CA3055660A1/en not_active Abandoned
- 2013-06-04 UA UAA201500086A patent/UA115665C2/uk unknown
- 2013-06-04 PT PT138006812T patent/PT2858985T/pt unknown
- 2013-06-04 JP JP2015516121A patent/JP6182209B2/ja active Active
- 2013-06-04 TW TW102119817A patent/TWI532732B/zh active
- 2013-06-04 PT PT191692755T patent/PT3533792T/pt unknown
- 2013-06-04 HU HUE18157435A patent/HUE050357T2/hu unknown
- 2013-06-04 MY MYPI2014703627A patent/MY187500A/en unknown
- 2013-06-04 PT PT181574351T patent/PT3348553T/pt unknown
- 2013-06-04 SI SI201331788T patent/SI3348553T1/sl unknown
- 2013-06-04 KR KR1020157000266A patent/KR102062024B1/ko active Active
- 2013-06-04 SG SG11201408140QA patent/SG11201408140QA/en unknown
- 2013-06-04 UA UAA201702779A patent/UA123142C2/uk unknown
- 2013-06-04 NZ NZ717683A patent/NZ717683A/en unknown
2014
- 2014-12-01 CR CR20140549A patent/CR20140549A/es unknown
- 2014-12-04 NI NI201400142A patent/NI201400142A/es unknown
- 2014-12-04 PH PH12014502714A patent/PH12014502714B1/en unknown
- 2014-12-04 IL IL236055A patent/IL236055A0/en unknown
- 2014-12-05 CL CL2014003331A patent/CL2014003331A1/es unknown
- 2014-12-05 EC ECIEPI201430098A patent/ECSP14030098A/es unknown
- 2014-12-05 GT GT201400283A patent/GT201400283A/es unknown
- 2014-12-09 CO CO14270612A patent/CO7240407A2/es unknown
2015
- 2015-01-06 ZA ZA2015/00076A patent/ZA201500076B/en unknown
- 2015-11-11 HK HK15111086.5A patent/HK1210175A1/xx unknown
2016
- 2016-07-26 PH PH12016501470A patent/PH12016501470B1/en unknown
- 2016-09-12 US US15/262,522 patent/US9994545B2/en active Active
- 2016-12-19 HK HK16114389A patent/HK1226066A1/zh unknown
2017
- 2017-01-17 AU AU2017200298A patent/AU2017200298B2/en active Active
- 2017-02-15 JP JP2017025746A patent/JP6345821B2/ja active Active
- 2017-12-22 AU AU2017279807A patent/AU2017279807B2/en active Active
2018
- 2018-05-09 US US15/975,449 patent/US10308630B2/en active Active
- 2018-05-23 JP JP2018098638A patent/JP2018141009A/ja active Pending
- 2018-05-31 IL IL259738A patent/IL259738B/en active IP Right Grant
- 2018-06-11 HR HRP20180902TT patent/HRP20180902T1/hr unknown
- 2018-07-06 CY CY20181100712T patent/CY1120393T1/el unknown
2019
- 2019-04-15 US US16/384,002 patent/US10526310B2/en active Active
- 2019-06-24 IL IL267608A patent/IL267608A/en unknown
- 2019-07-10 US US16/507,780 patent/US10556882B2/en active Active
- 2019-12-11 US US16/710,785 patent/US10766875B2/en active Active
2020
- 2020-06-15 IL IL275413A patent/IL275413A/en unknown
- 2020-07-29 US US16/942,069 patent/US10934271B2/en active Active
- 2020-08-31 HR HRP20201387TT patent/HRP20201387T1/hr unknown
- 2020-09-23 CY CY20201100901T patent/CY1123427T1/el unknown
2021
- 2021-01-26 US US17/158,806 patent/US12018008B2/en active Active
- 2021-06-08 HR HRP20210909TT patent/HRP20210909T1/hr unknown
- 2021-07-02 CY CY20211100595T patent/CY1124831T1/el unknown
- 2021-11-02 NO NO2021046C patent/NO2021046I1/no unknown
- 2021-11-02 LU LU00236C patent/LUC00236I2/fr unknown
- 2021-11-03 LT LTPA2021525C patent/LTPA2021525I1/lt unknown
- 2021-11-03 NL NL301144C patent/NL301144I2/nl unknown
- 2021-11-03 FR FR21C1050C patent/FR21C1050I2/fr active Active
- 2021-11-04 HU HUS2100047C patent/HUS2100047I1/hu unknown
- 2021-11-04 CY CY2021032C patent/CY2021032I2/el unknown
2024
- 2024-05-13 US US18/662,345 patent/US20250092011A1/en active Pending

Also Published As

Publication number	Publication date
IL275413A (en)	2020-07-30
HRP20180902T1 (hr)	2018-08-24
EP3533792A1 (en)	2019-09-04
UA123142C2 (uk)	2021-02-24
EP2858985B1 (en)	2018-04-18
CY1120393T1 (el)	2019-07-10
ZA201500076B (en)	2016-10-26
IN2014DN10084A (hu)	2015-08-21
PT3533792T (pt)	2021-06-07
DK2858985T3 (en)	2018-05-28
ES2875932T3 (es)	2021-11-11
SI3533792T1 (sl)	2021-11-30
US10766875B2 (en)	2020-09-08
WO2013184681A1 (en)	2013-12-12
NZ702203A (en)	2016-09-30
PH12016501470B1 (en)	2021-12-10
GT201400283A (es)	2017-07-03
US10308630B2 (en)	2019-06-04
SI3348553T1 (sl)	2020-11-30
UA115665C2 (uk)	2017-12-11
HRP20210909T1 (hr)	2021-09-03
US20190330182A1 (en)	2019-10-31
RS60617B1 (sr)	2020-09-30
PL3533792T3 (pl)	2021-11-29
PL2858985T3 (pl)	2018-09-28
FR21C1050I1 (fr)	2021-12-10
EA028791B1 (ru)	2017-12-29
KR20150021993A (ko)	2015-03-03
US10526310B2 (en)	2020-01-07
CA3008345A1 (en)	2013-12-12
SI2858985T1 (sl)	2018-12-31
LTPA2021525I1 (hu)	2021-11-25
CY1124831T1 (el)	2022-03-24
CA2875767C (en)	2018-08-14
SMT202100355T1 (it)	2021-07-12
CL2014003331A1 (es)	2016-03-04
KR102062024B1 (ko)	2020-01-03
SMT202000496T1 (it)	2020-11-10
CA2875767A1 (en)	2013-12-12
AU2013271751A1 (en)	2014-12-18
US12018008B2 (en)	2024-06-25
CA3008345C (en)	2019-10-22
EA201492272A1 (ru)	2015-05-29
HUE054595T2 (hu)	2021-09-28
JP2015518890A (ja)	2015-07-06
PE20200725A1 (es)	2020-07-21
EP2858985A1 (en)	2015-04-15
KR20190132543A (ko)	2019-11-27
PL3348553T3 (pl)	2021-02-08
AU2017279807B2 (en)	2018-11-08
US20150133481A1 (en)	2015-05-14
US10556882B2 (en)	2020-02-11
IL236055A0 (en)	2015-02-01
HUE038082T2 (hu)	2018-09-28
RS61988B1 (sr)	2021-07-30
LT3533792T (lt)	2021-07-26
MY187500A (en)	2021-09-24
PH12014502714A1 (en)	2015-02-02
NI201400142A (es)	2016-12-02
US10934271B2 (en)	2021-03-02
CN104619692A (zh)	2015-05-13
EP3533792B1 (en)	2021-05-05
US9481663B2 (en)	2016-11-01
CN105693692A (zh)	2016-06-22
SG11201408140QA (en)	2015-01-29
JP6345821B2 (ja)	2018-06-20
JP2018141009A (ja)	2018-09-13
MX356754B (es)	2018-06-11
TR201808939T4 (tr)	2018-07-23
CO7240407A2 (es)	2015-04-17
LUC00236I2 (hu)	2025-02-03
ME03815B (me)	2021-04-20
EP3348553A1 (en)	2018-07-18
SG10201610249TA (en)	2017-02-27
IL259738B (en)	2021-06-30
LT2858985T (lt)	2018-09-25
US20200115361A1 (en)	2020-04-16
IL267608A (en)	2019-08-29
PT3348553T (pt)	2020-09-28
KR102195916B1 (ko)	2020-12-30
LT3348553T (lt)	2020-09-25
US20170001977A1 (en)	2017-01-05
CN113135892A (zh)	2021-07-20
HK1226066A1 (zh)	2017-09-22
EP3922629A1 (en)	2021-12-15
CA3114726A1 (en)	2013-12-12
PE20150631A1 (es)	2015-05-11
JP6182209B2 (ja)	2017-08-16
EP2858985A4 (en)	2016-05-25
CR20140549A (es)	2015-04-06
NZ717683A (en)	2018-04-27
TW201402561A (zh)	2014-01-16
US9994545B2 (en)	2018-06-12
AU2017200298A1 (en)	2017-02-02
MX2014015005A (es)	2015-09-04
AU2013271751B2 (en)	2017-02-23
NL301144I2 (nl)	2025-03-20
US20200354335A1 (en)	2020-11-12
ME03081B (me)	2019-01-20
CA3055660A1 (en)	2013-12-12
HK1210175A1 (en)	2016-04-15
US20250092011A1 (en)	2025-03-20
FR21C1050I2 (fr)	2024-05-24
EA033956B1 (ru)	2019-12-13
EA201992010A1 (ru)	2020-01-24
BR112014030678A2 (pt)	2017-06-27
IL259738A (en)	2018-07-31
HRP20201387T1 (hr)	2020-11-27
CY2021032I2 (el)	2022-03-24
US20210163441A1 (en)	2021-06-03
CR20190331A (es)	2019-11-12
ES2809738T3 (es)	2021-03-05
EP3348553B1 (en)	2020-07-08
CY2021032I1 (hu)	2022-03-24
ECSP14030098A (es)	2016-01-29
EA201791592A1 (ru)	2018-01-31
DK3348553T3 (da)	2020-07-27
SG10201610248SA (en)	2017-02-27
NO2021046I1 (no)	2021-11-02
ES2670683T3 (es)	2018-05-31
HUE050357T2 (hu)	2020-11-30
PH12014502714B1 (en)	2015-02-02
DK3533792T3 (da)	2021-06-28
AU2017200298B2 (en)	2017-09-28
PT2858985T (pt)	2018-07-10
JP2017178923A (ja)	2017-10-05
PH12016501470A1 (en)	2017-07-10
US20180258067A1 (en)	2018-09-13
TWI532732B (zh)	2016-05-11
US20190241539A1 (en)	2019-08-08
AU2017279807A1 (en)	2018-01-25
RS57370B1 (sr)	2018-08-31
SMT201800311T1 (it)	2018-07-17
CY1123427T1 (el)	2021-12-31

Publication	Publication Date	Title
HUS2100047I1 (hu)	2021-11-29	Egy androgén receptor modulátor kristályos formái
HK1258404A1 (zh)	2019-11-08	雄激素受體表達的調節
EP2911666A4 (en)	2016-10-12	MODULATORS OF A RESISTANT ANDROGEN RECEPTOR
IL231440A0 (en)	2014-04-30	Selective androgen receptor modulators
ME02996B (me)	2018-10-20	Indolkarb0niтrili као selekтivni modulatori receptora androgena
TH1401007292A (th)	2016-09-20	รูปแบบผลึกของแอนโดรเจนรีเซปเตอร์มอดูเลเตอร์